Diagnostics
Nucleic-acid-based assays are the gold standard for detecting the presence of the SARS-CoV-2 virus, but they eventually will be replaced with simpler and more advanced techniques, such as CRISPR-Cas, LAMP, and other faster and less-expensive methods.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 1, 2020.
California-based Grail aims to alter the devastating trajectory of cancer mortality with the addition of one simple blood test.
Guardant Health is taking Roche-owned Foundation Medicine to court over a patent dispute for their liquid biopsy technology, further heating up the rivalry between the two cancer detection companies.
As of late, the company has already tested almost 15,000 of its 75,000 employees in a pilot program.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 24, 2020.
Biopharma and life sciences companies strengthen their leadership teams and boards with these Movers & Shakers.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 17, 2020.
Abbott is suing their former VP Jerome Clavel over allegations of trade secret theft with intent to share with his new employer, rival diagnostics company Bio-Rad.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for November 3, 2020.
PRESS RELEASES